We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
The meeting of the Advisory Committee on Vaccines (ACV).
The committee provided advice on the:
- extension of indication for a vaccine with provisional registration for active immunisation to prevent COVID-19 (product name Spikevax; active ingredient Elasomeran; sponsor Moderna Australia Pty Ltd) that had been under evaluation from November 2021.
The committee provided advice on the following safety matter.
- Risk of Haemophagocytic lymphohistiocytosis (HLH) associated with Vaxzevria (formerly known as COVID-19 vaccine AstraZeneca)
Members
Membership comprises professionals with expertise in specific scientific, medical or clinical fields, or consumer health issues.